| |
| |
|
| Insider
Information: |
Chen Isan |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
232,184 |
|
|
Indirect Shares
|
110 |
|
|
| Direct
Value |
$2,312,839 |
|
|
|
Indirect Value
|
$6,457 |
|
|
| Total
Shares |
232,294 |
|
|
| Total
Value |
$2,319,296 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mirati Therapeutics, Inc. |
MRTX |
|
2020-05-11 |
39,401 |
2018-07-16 |
110 |
Premium* |
|
|
Tyra Biosciences, Inc. |
TYRA |
Director |
2021-09-17 |
192,783 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TYRA |
Tyra Biosciences, Inc. |
Director |
– • – |
2021-09-17 |
4 |
A |
$0.00 |
$0 |
D/D |
61,444 |
192,783 |
0 |
- |
|
| TYRA |
Tyra Biosciences, Inc. |
Director |
– • – |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
131,339 |
|
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Medical Officer |
• – – |
2020-05-11 |
4 |
AS |
$105.00 |
$3,500,070 |
D/D |
(33,334) |
39,401 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Medical Officer |
• – – |
2020-05-11 |
4 |
OE |
$24.99 |
$833,017 |
D/D |
33,334 |
72,735 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Medical Officer |
• – – |
2020-01-29 |
4 |
OE |
$24.99 |
$75,020 |
D/D |
3,002 |
39,401 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Medical Officer |
• – – |
2019-01-23 |
4 |
OE |
$5.40 |
$19,547 |
D/D |
870 |
35,836 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Medical Officer |
• – – |
2018-07-16 |
4 |
OE |
$17.41 |
$39,032 |
D/D |
1,867 |
34,582 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Medical Officer |
• – – |
2018-04-25 |
4 |
OE |
$5.40 |
$220,817 |
D/D |
13,038 |
31,836 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Sr.Vice President, Chief Medi |
• – – |
2016-01-13 |
4 |
OE |
$15.79 |
$40,138 |
D/D |
2,542 |
18,113 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Chief Medical & Devt Officer |
• – – |
2015-03-09 |
4 |
OE |
$15.79 |
$199,996 |
D/D |
12,666 |
12,666 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
Chief Medical & Devt OfficerOf |
• – – |
2013-09-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
110 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
